Adelaida Resuello, MD
Pediatrics · Las Vegas, NVNPI 1194786582
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 211 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 22 manufacturers reported payments, led by AstraZeneca at 51.1% of the total. Reporting peaked in 2021 at $976 and has fallen 54.5% since, to $444 in 2025. Among pediatrics clinicians in NV with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 211 payments — averaging $21.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$2K
- GSK$508
- Novo Nordisk$344
- Novartis$253
- Amgen$151
- Merck$125
- plus $840 from 16 others
What the payments were for
- Food & beverage$4,539100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 99 | $2,319 |
| GSK | 26 | $508 |
| Novo Nordisk | 19 | $344 |
| Novartis | 8 | $253 |
| Amgen(2 entities) | 7 | $151 |
| Merck | 8 | $125 |
| Boehringer Ingelheim | 7 | $114 |
| Aimmune Therapeutics, Inc. | 2 | $105 |
| Kowa Pharmaceuticals America, Inc. | 5 | $95 |
| Amarin Pharma, Inc. | 6 | $91 |
| Lilly USA, LLC | 4 | $75 |
| Johnson & Johnson | 4 | $60 |
| Exact Sciences | 3 | $57 |
| Bayer | 3 | $57 |
| Genentech USA, Inc. | 3 | $54 |
| Nestle Healthcare Nutrition Inc. | 1 | $25 |
| Abbott | 1 | $23 |
| Medicure Pharma Inc. | 1 | $21 |
| Eisai Inc. | 1 | $18 |
| Qiagen, LLC | 1 | $17 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$4,539 in reported general payments places this provider in the 95th percentile of 327 pediatrics providers in Nevada.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| TrulicityDulaglutide | 38 | $67,842 |
| JanuviaSitagliptin Phosphate | 38 | $50,468 |
| JardianceEmpagliflozin | 23 | $20,940 |
| EliquisApixaban | 13 | $13,752 |
| Tresiba Flextouch U-100Insulin Degludec | 13 | $4,976 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 58 | $2,398 |
| Atorvastatin Calcium | 310 | $2,267 |
| Ventolin HfaAlbuterol Sulfate | 13 | $1,383 |
| Losartan-HydrochlorothiazideLosartan/Hydrochlorothiazide | 71 | $1,305 |
| Losartan Potassium | 161 | $1,256 |
| Amlodipine Besylate | 181 | $808 |
| Candesartan Cilexetil | 15 | $783 |
| Allopurinol | 105 | $768 |
| Metoprolol Succinate | 46 | $757 |
| Potassium Chloride | 33 | $681 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Lilly USA, LLCTrulicity | $75 | $67,84238 claims |
| MerckJanuvia | $125 | $50,46838 claims |
| Boehringer IngelheimJardiance | $114 | $20,94023 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 327 pediatrics providers in Nevada.
Other pediatrics in Las Vegas
- Carolina KoleticLas Vegas$80K
- Ryan YoshikawaLas Vegas$10K
- Trisha BrionesLas Vegas$7K
- Kathleen ReardonLas Vegas$4K
- Michael TenbyLas Vegas$3K
- Jennifer BuitragoLas Vegas$3K
- Maria Desquitado-TaboraLas Vegas$3K
- Huynh Truong VuLas Vegas$2K
- Arlene BayrederLas Vegas$2K
- Grace Cano DebelenLas Vegas$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.